Finally, these findings accord with the growing consensus that TNFα, IL-6 and CRP are among the important biomarkers with translational potential in mood disorders, suggesting that this may be true in the psychological as well as pharmacological treatment of depression. This evidence concerns the gene CRP and major depressive disorder.